|
Report Date : |
15.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
BORG FOR PHARMACEUTICAL INDUSTRIES |
|
|
|
|
Registered Office : |
New Borg El Arab
City, 3rd Industrial Zone, Block 17, Plot 3, P O Box 160, Alexandria |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Year of Establishments: |
2001 |
|
|
|
|
Com. Reg. No.: |
1228, Alexandria |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceuticals and cosmetics |
|
|
|
|
No. of Employees : |
250 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Egypt - ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to attract foreign investment and facilitate GDP growth. Despite the relatively high levels of economic growth in recent years, living conditions for the average Egyptian remained poor and contributed to public discontent. After unrest erupted in January 2011, the Egyptian Government drastically increased social spending to address public dissatisfaction, but political uncertainty at the same time caused economic growth to slow significantly, reducing the government's revenues. Tourism, manufacturing, and construction are among the hardest hit sectors of the Egyptian economy, and economic growth is likely to remain slow at least through 2012. The government is utilizing foreign exchange reserves to support the Egyptian pound and Egypt may seek a loan from the International Monetary Fund.
|
Source : CIA |
Company Name : BORG FOR PHARMACEUTICAL INDUSTRIES
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 2001
Commercial Registration Number : 1228, Alexandria
Authorised Capital : £E 70,000,000
Issued Capital : £E 50,000,000
Paid up Capital : £E 50,000,000
Total Workforce : 250
Activities : Manufacture of pharmaceuticals and cosmetics.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
BORG FOR PHARMACEUTICAL INDUSTRIES
Registered &
Physical Address
Location : New Borg El Arab City, 3rd Industrial
Zone, Block 17, Plot 3
PO Box : 160
Town : Alexandria
Country : Egypt
Telephone : (20-3) 4596931 / 4596932 / 4596933 /
4596934
Facsimile : (20-3) 4596930
Mobile : (20-122) 2114237
Premises
Subject operates
from a large suite of offices and a factory that are owned and located in the
Industrial Area of Alexandria.
Branch Office (s)
Location Description
·
22 Mohamed Saleh Abu Youssef Rented Sales
Office
El Bostan
Alexandria
Tel: (20-3) 5847019
Fax: (20-3) 5847050
·
Building
No. 2 Rented Sales Office
Block 21, Ahmed El Zomor Street
Emtidad Zaker Hussein, 10 District
Nasr City
Cairo
·
El Nahda Building Rented Sales Office
Sarayat
El Maadi, Maadi
Cairo
Tel: (20-2)
23598548
Fax: (20-2)
23598548
Name Position
·
Dr Hussein Tharwat Hagar Chairman
·
Dr Hisham Hussein Tharwat Hagar Vice
Chairman
·
El Sayed Mohamed Hassan Finance
Manager
·
Aml Hamza Administration
Manager
·
Ahmed
Arous Sales
Manager
·
Jental
Soltan Production
Manager
Date of Establishment : 2001
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 1228,
Alexandria
Authorised
Capital : £E 70,000,000
Issued Capital : £E 50,000,000
Paid up Capital : £E 50,000,000
Name of
Shareholder (s)
·
Dr Hussein Tharwat Hagar
·
Hisham Hussein Tharwat Hagar
Activities: Engaged in the manufacture of cosmetics and
pharmaceuticals, including cough and catarrh preparations, blood tonics, depuratives and salt tablets.
Import
Countries: Europe and the
United States of America.
Export Countries: Yemen, Qatar, Kenya and Oman.
Operating Trend: Steady
Subject has a
workforce of approximately 250 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/11: Year
Ending 31/12/12:
Total Sales £E 24,220,000 £E 25,750,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
Egyptian
Gulf Bank
El Orman Plaza Building
8-10 Ahmed Nessim Street
PO Box: 56
Cairo
Tel: (20-2) 33606580 / 33606467
Fax: (20-2) 33420265 / 33606512
·
Commercial
International Bank (CIB)
61 Sultan Hussein Street
Alexandria
Tel: (20-3) 4824643 / 4834255
Fax: (20-3) 4832240
·
Delta
International Bank
El Shallalat Branch
Alexandria
Tel: (20-3) 3938527 / 3938528
Fax: (20-3) 3938543
No complaints regarding
subject’s payments have been reported.
Amount overdue 0
Payment terms 90
days
Payment Method Letters
of Credit
Paying record No
Complaints
Currency US
Dollars
During the course of
this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.44 |
|
UK Pound |
1 |
Rs.81.33 |
|
Euro |
1 |
Rs.70.50 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.